Literature DB >> 15609153

Pricing and reimbursement of pharmaceuticals in Portugal.

C Gouveia Pinto1, I Teixeira.   

Abstract

The pricing and reimbursement systems in Portugal are quite complex. This is due not only to the general characteristics of the Portuguese NHS but also to the past evolution of these systems. In this article we explain the main features of pharmaceutical policy in Portugal regarding pricing and reimbursement of medicines. Causes of government concern with expenditure and policies aiming at controlling it are pointed out. Policies are described through presentation of the most recent legislation approved on the issues analysed.

Year:  2002        PMID: 15609153     DOI: 10.1007/s10198-002-0146-1

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  2 in total

1.  Effects of economic recession on elderly patients' perceptions of access to health care and medicines in Portugal.

Authors:  Filipa Alves da Costa; Inês Teixeira; Filipa Duarte-Ramos; Luís Proença; Ana Rita Pedro; Cristina Furtado; José Aranda da Silva; José Cabrita
Journal:  Int J Clin Pharm       Date:  2016-12-09

2.  The Portuguese generic medicines market: a policy analysis.

Authors:  Steven Simoens
Journal:  Pharm Pract (Granada)       Date:  2009-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.